Serum B12 tells you how much cobalamin is circulating; active B12 and MMA tell you whether enough is reaching cells. That distinction matters when numbness, fatigue, brain fog, metformin use, vegan diets, or gut surgery make a normal-looking B12 result hard to trust.
- Active B12 test measures holotranscobalamin, the cell-deliverable fraction of B12; many labs treat <35 pmol/L as low and 35-50 pmol/L as borderline.
- MMA test measures methylmalonic acid; serum MMA above about 0.40 µmol/L supports cellular B12 deficiency when kidney function is normal.
- Serum B12 can look normal at 300-500 pg/mL while symptoms persist, especially after recent supplements or in liver disease, kidney disease, or altered binding proteins.
- Holotranscobalamin often falls before anemia appears because it reflects B12 available to tissues rather than total circulating B12.
- Methylmalonic acid test is more functional but less specific in chronic kidney disease; eGFR below 60 mL/min/1.73 m² can raise MMA without true B12 deficiency.
- CBC results may be completely normal in early B12 deficiency; MCV above 100 fL is a late clue, not a screening guarantee.
- High-risk groups include vegans, people after bariatric surgery, older adults, metformin users, long-term acid blocker users, and patients with autoimmune gastritis or ileal disease.
- Follow-up testing is usually most useful 8-12 weeks after consistent B12 treatment, with MMA expected to fall earlier than MCV or neurological recovery.
When a Normal Serum B12 Result Is Not Enough
A normal serum B12 result does not always exclude functional deficiency. If symptoms or risk factors fit, an active B12 test for holotranscobalamin plus an MMA test can show whether B12 is actually reaching cells. As of May 28, 2026, I usually trust the pair more than total B12 alone when the result sits in the grey zone.
Serum B12 usually reports total cobalamin, with many laboratories using roughly 200-900 pg/mL or 148-665 pmol/L as an adult reference interval. Kantesti is an AI blood test analyzer that flags a normal-looking B12 result differently when neuropathy, macrocytosis, metformin use, or a vegan diet appear in the same report or patient history; our organization details are available on About Us.
I’m Thomas Klein, MD, and the pattern I see most often is not dramatic: a 41-year-old patient with tingling feet, serum B12 of 382 pg/mL, MCV of 91 fL, and no anemia. The usual single-number answer says “normal,” but their holotranscobalamin returns 24 pmol/L and MMA 0.62 µmol/L, which changes the clinical conversation completely.
Stabler’s 2013 New England Journal of Medicine review described the same problem clinically: neurological B12 deficiency can occur without classic anemia, and biomarkers have to be interpreted in combination rather than as isolated proof (Stabler, 2013). If your symptoms match that pattern, our deeper piece on normal B12 symptoms is a useful companion.
What Holotranscobalamin Actually Measures
Holotranscobalamin measures the fraction of vitamin B12 attached to transcobalamin, the carrier that delivers B12 into cells. This is why it is often called active B12, even though it represents only about 10-30% of circulating B12.
Total B12 includes B12 bound to haptocorrin, a carrier that stores or transports B12 but does not efficiently deliver it into most cells. Holotranscobalamin is the smaller, clinically interesting fraction because cells take up the transcobalamin-B12 complex through receptor-mediated transport.
A common adult holotranscobalamin reference pattern is >50 pmol/L as generally adequate, 35-50 pmol/L as indeterminate, and <35 pmol/L as suspicious for deficiency. Some European laboratories use different assay-specific cutoffs, so a value of 38 pmol/L may be labelled “borderline” in one report and “low-normal” in another.
The British Committee for Standards in Haematology guideline led by Devalia in 2014 recommended considering MMA or holotranscobalamin when serum B12 is equivocal and clinical suspicion remains (Devalia et al., 2014). For readers comparing older B12 reports with newer assays, our vitamin B12 testing guide explains why reference intervals are not interchangeable.
In Kantesti AI review sessions, I see holotranscobalamin behave like a supply-chain marker: it often drops before the warehouse looks empty. That is clinically handy, but it is not perfect; pregnancy, recent supplementation, and assay variation can all blur the signal.
What the MMA Test Adds to Active B12
The MMA test measures methylmalonic acid, which rises when cells lack enough B12 to run methylmalonyl-CoA mutase. In adults with normal kidney function, serum MMA above about 0.40 µmol/L is a strong clue for cellular B12 deficiency.
MMA is not a vitamin level; it is a metabolic back-pressure marker. When intracellular B12 is inadequate, methylmalonyl-CoA is not converted efficiently to succinyl-CoA, and methylmalonic acid spills upward in serum or urine.
Many laboratories report serum MMA reference intervals around 0.00-0.40 µmol/L, while some use upper limits closer to 0.28 µmol/L. A result of 0.52 µmol/L is more persuasive when eGFR is 92 mL/min/1.73 m² than when eGFR is 42 mL/min/1.73 m².
Hannibal and colleagues’ 2016 Frontiers in Molecular Biosciences review emphasized that no single B12 biomarker is ideal, and diagnostic algorithms perform better when MMA, holotranscobalamin, total B12, renal function, and symptoms are combined (Hannibal et al., 2016). Our B12 range guide covers the total B12 side of that algorithm.
In practice, I treat MMA as a functional smoke alarm rather than a standalone diagnosis. It tells me something is burning in the B12 pathway, but I still check whether kidney function, dehydration, small intestinal bacterial overgrowth, or rare metabolic conditions could be making the alarm too sensitive.
How to Interpret Holotranscobalamin and MMA Together
Low holotranscobalamin plus high MMA is the clearest lab pattern for functional B12 deficiency. Normal holotranscobalamin with normal MMA makes clinically significant deficiency less likely, though it does not explain every neurological symptom.
The most useful pair is holotranscobalamin <35 pmol/L with MMA >0.40 µmol/L, especially when eGFR is above 60 mL/min/1.73 m². That combination suggests poor B12 delivery and a measurable metabolic consequence.
A low active B12 with normal MMA often means early deficiency, recent dietary change, pregnancy-related dilution, or a lab grey zone. I would not dismiss symptoms in that situation; I would ask about nitrous oxide exposure, gastric surgery, autoimmune disease, and whether supplements were started before testing.
High MMA with normal active B12 is the tricky box. In a patient with numbness or balance symptoms, I re-check total B12, folate, eGFR, and sometimes homocysteine; our guide to numbness lab clues lays out the broader differential.
Reference Ranges and Grey Zones Across Labs
Active B12 and MMA cutoffs vary because assays, populations, and units differ between laboratories. A holotranscobalamin value of 42 pmol/L or an MMA of 0.36 µmol/L should be read as a probability signal, not a verdict.
Serum B12 may be reported in pg/mL, ng/L, or pmol/L; 1 pg/mL is approximately 0.738 pmol/L for cobalamin. Holotranscobalamin is usually reported in pmol/L, while MMA is commonly reported in µmol/L or nmol/L.
The practical grey zone for total B12 is often 200-350 pg/mL, but I have seen symptomatic patients with functional markers abnormal at 450 pg/mL after taking multivitamins. A recent oral B12 dose of 500-1000 µg can lift serum B12 before MMA has fully normalized.
Kantesti’s neural network checks units before interpreting a result because unit mismatch is one of the dullest but most dangerous lab-report errors. If you are comparing reports from different countries, our article on lab unit changes can prevent a false alarm.
Symptoms That Justify Functional B12 Testing
Functional B12 testing is reasonable when neurological symptoms persist despite a normal serum B12 result. Tingling, burning feet, balance problems, memory change, glossitis, unexplained fatigue, and new low mood are the symptoms I take most seriously.
B12-related nerve symptoms often start symmetrically in the toes or soles and may progress slowly over weeks to months. The uncomfortable truth is that neurological recovery can lag behind lab correction by 3-12 months, and some deficits can persist if treatment is delayed.
Fatigue alone is nonspecific, but fatigue plus sore tongue, pins-and-needles, memory fog, and borderline MCV is a different story. In my experience, the “I feel wired and weak at the same time” description often overlaps with B12, thyroid, ferritin, sleep disruption, or glucose swings.
A normal active B12 and MMA pair does not mean symptoms are imaginary. It means the B12 pathway is less likely to be the main driver, and a broader workup such as fatigue blood tests may be more helpful.
Risk Factors That Make Serum B12 Falsely Reassuring
Serum B12 is more likely to mislead in people with low intake, poor absorption, altered binding proteins, or recent supplementation. Vegans, older adults, metformin users, acid-blocker users, and patients after bariatric or ileal surgery deserve a lower threshold for active B12 and MMA testing.
Kantesti is an AI blood test interpretation platform that treats B12 differently when a patient’s history includes vegan eating for more than 1-2 years, gastric bypass, ileal resection, coeliac disease, Crohn’s disease, or autoimmune gastritis. Those risk factors can lower tissue B12 before the serum value crosses the laboratory’s red line.
Metformin is a common one. After 4-5 years of regular use, B12 deficiency becomes clinically relevant enough that many clinicians check B12 periodically, especially when neuropathy appears in a person whose glucose numbers look stable.
Long-term proton pump inhibitors and H2 blockers reduce gastric acid, which can impair release of food-bound B12. People following plant-based diets should also read our practical vegan lab checklist, because ferritin, iodine, vitamin D, and omega-3 status often travel with the same story.
Kidney Function and Other Causes of High MMA
High MMA is less specific when kidney function is reduced. An eGFR below 60 mL/min/1.73 m² can raise methylmalonic acid because the kidneys clear MMA less efficiently, even when B12 delivery is adequate.
A serum MMA of 0.55 µmol/L with eGFR 95 means something different from the same MMA with eGFR 38. In older adults, this distinction is not academic; mild chronic kidney disease is common and can convert a borderline MMA into a false B12 alarm.
Dehydration, recent intense exercise, and acute illness can also distort the metabolic context, although they are less classic confounders than kidney function. I usually want creatinine, eGFR, hydration clues, and sometimes cystatin C before calling a borderline MMA diagnostic.
If kidney numbers are changing, compare the MMA with a proper renal trend rather than a single creatinine. Our eGFR by age article explains why a creatinine that looks “normal” can still hide reduced filtration in a smaller or older person.
Why CBC Results Can Be Normal in B12 Deficiency
A normal CBC does not rule out early or neurological B12 deficiency. Macrocytosis, usually defined as MCV above 100 fL, is a late or inconsistent sign and can be masked by iron deficiency or thalassaemia trait.
Classic teaching says B12 deficiency causes macrocytic anemia, but real patients are messier. A person with low ferritin may have smaller cells, while B12 deficiency pushes cell size upward; the average MCV can land at 88-94 fL and look deceptively tidy.
I pay attention to RDW, neutrophil morphology if a smear is done, hemoglobin trend, and platelet count, not just MCV. An MCV rise from 84 to 96 fL over two years may matter even if the lab never prints an H flag.
The pattern of B12 deficiency without anemia deserves respect because nerves can be affected before hemoglobin falls below 12 g/dL in women or 13 g/dL in men. For a deeper look at this mismatch, see our article on B12 without anemia.
Homocysteine, Folate, and the MTHFR Distraction
Homocysteine can support a B12 diagnosis, but it is less specific than MMA. Levels above about 15 µmol/L may reflect B12 deficiency, folate deficiency, B6 deficiency, hypothyroidism, kidney disease, genetics, smoking, or medication effects.
MMA is more specific to B12-dependent methylmalonyl-CoA metabolism, while homocysteine sits at a busy crossroads involving B12, folate, B6, thyroid status, renal function, and inflammation. That is why a homocysteine of 18 µmol/L is useful but not decisive.
Folate can partly correct the anemia of B12 deficiency while neurological injury continues, which is why high-dose folic acid without B12 assessment makes me uneasy in symptomatic patients. This is especially relevant when folate is >20 ng/mL and B12 markers are borderline.
MTHFR results can distract from the immediate clinical question: is there enough functional B12 in cells today? Our homocysteine range guide and folate comparison piece explain where genetics fits, and where it really does not.
Testing Logistics: Fasting, Units, and Retesting
Active B12 and MMA usually do not require fasting, but timing still matters. Recent high-dose B12 supplements can raise serum B12 and holotranscobalamin within days, while MMA may take 1-3 weeks to fall after effective treatment.
If you have not started supplements and symptoms are stable, testing before treatment gives the cleanest baseline. If you already took 1000 µg/day of B12 for two weeks, a normal serum B12 does not prove the original status was normal.
Serum MMA is usually preferred over urine MMA for routine adult interpretation because it is easier to pair with eGFR and other serum markers. Urine MMA can be useful in specific settings, but hydration and creatinine correction become part of the story.
Fasting is usually more relevant to glucose, lipids, and some metabolic panels than to B12 markers. Our fasting test rules article explains which results shift after meals and which usually do not.
What Follow-Up Looks Like After B12 Treatment
MMA usually improves before symptoms fully recover after B12 treatment. A practical follow-up interval is 8-12 weeks after consistent oral or injectable therapy, unless neurological symptoms are worsening and need earlier medical review.
Oral cyanocobalamin or methylcobalamin doses of 1000-2000 µg/day can work well for many patients because passive absorption still occurs at high doses. In pernicious anemia, severe neurological symptoms, or post-bariatric malabsorption, clinicians may choose injections such as 1000 µg on a structured schedule.
I do not expect numbness to vanish in a week. Reticulocytes may rise within 5-10 days if anemia is present, MMA may fall within 1-3 weeks, and neurological recovery often takes 3-12 months depending on duration and severity.
Thomas Klein, MD advice here is deliberately boring: do not chase daily symptom swings with daily supplement changes. Use a stable plan, document dose and form, then compare objective markers using our low B12 supplement follow-up framework.
How Kantesti Reads Active B12 Results in Context
Kantesti interprets active B12 test results by combining holotranscobalamin, MMA, total B12, CBC indices, kidney function, medications, diet pattern, and symptom clues. That context-based reading is safer than treating any single number as a diagnosis.
Kantesti is an AI-powered blood test analysis tool used by more than 2M people across 127+ countries, and our B12 logic is designed to avoid both under-calling neuropathy risk and over-calling deficiency in kidney disease. The marker library behind that work is described in our biomarkers guide.
Our AI biomarker interpretation platform does not mark MMA high in isolation and stop there. It checks whether eGFR is below 60, whether MCV has drifted upward by 5-10 fL, whether ferritin or folate could mask anemia, and whether metformin or acid blockers are visible in the medication history.
The clinical standards behind Kantesti AI are reviewed against physician-led benchmarks, including our medical validation process. We also publish validation work such as the AI engine benchmark, which describes rubric-based testing across anonymised blood test cases.
When to Seek Medical Care and What to Ask
Seek medical care promptly if B12-related symptoms are progressive, neurological, or paired with anemia. New difficulty walking, falls, weakness, confusion, severe numbness, or hemoglobin below about 10 g/dL deserves clinician review rather than supplement trial-and-error.
Bring three questions: What is my holotranscobalamin? What is my MMA with eGFR? Could iron, folate, thyroid disease, diabetes, alcohol, medications, or autoimmune gastritis explain this pattern? A focused conversation saves weeks of guessing.
If the results are mixed, ask whether repeat testing after 8-12 weeks of consistent treatment is appropriate and whether pernicious anemia testing is needed. Intrinsic factor antibody is specific but not perfectly sensitive; a negative result does not always end the investigation.
Kantesti’s medical content is reviewed with physician oversight, including input from our Medical Advisory Board. Thomas Klein, MD bottom line: if serum B12 looks normal but your story sounds like B12 deficiency, active B12 plus MMA is one of the cleanest ways to move from vague worry to a testable plan.
Frequently Asked Questions
Can you have B12 deficiency with a normal serum B12 level?
Yes, functional B12 deficiency can occur when serum B12 is normal, especially if the result is in the borderline range of about 200-500 pg/mL and symptoms or risk factors are present. Serum B12 measures total circulating cobalamin, not necessarily the amount delivered into cells. Low holotranscobalamin, often below 35 pmol/L, plus MMA above about 0.40 µmol/L supports tissue-level B12 deficiency when kidney function is normal.
What does an active B12 test measure?
An active B12 test measures holotranscobalamin, the vitamin B12 fraction attached to transcobalamin and available for cellular uptake. Holotranscobalamin usually represents about 10-30% of total circulating B12. Many laboratories interpret values above 50 pmol/L as adequate, 35-50 pmol/L as borderline, and below 35 pmol/L as suspicious for deficiency.
Is the MMA test better than the serum B12 test?
The MMA test is often better for detecting functional B12 deficiency because methylmalonic acid rises when B12-dependent metabolism slows inside cells. Serum MMA above about 0.40 µmol/L supports B12 deficiency if eGFR is normal. MMA is not perfect, because chronic kidney disease, especially eGFR below 60 mL/min/1.73 m², can raise MMA without true B12 deficiency.
What MMA level suggests B12 deficiency?
A serum MMA level above about 0.40 µmol/L suggests possible functional B12 deficiency in adults with normal kidney function. Some laboratories use lower upper limits, such as 0.28 µmol/L, so the lab’s own reference range matters. The result is strongest when paired with holotranscobalamin below 35 pmol/L, compatible symptoms, and eGFR above 60 mL/min/1.73 m².
Can kidney disease cause a high methylmalonic acid test?
Yes, kidney disease can raise methylmalonic acid because MMA is partly cleared by the kidneys. An eGFR below 60 mL/min/1.73 m² makes a mildly high MMA less specific for B12 deficiency. In that situation, clinicians usually interpret MMA alongside holotranscobalamin, total B12, CBC trends, symptoms, and sometimes homocysteine.
Should I stop B12 supplements before an active B12 or MMA test?
Do not stop prescribed B12 treatment without your clinician’s advice, especially if you have neurological symptoms. If you started over-the-counter B12 recently, tell your clinician because 500-1000 µg/day can raise serum B12 and holotranscobalamin within days. MMA may take 1-3 weeks to improve after effective treatment, so supplement timing can change how results are interpreted.
How soon should active B12 and MMA be retested after treatment?
Active B12 and MMA are often retested after 8-12 weeks of consistent B12 treatment. MMA may fall within 1-3 weeks, but symptoms and CBC changes can take longer. Neurological recovery often takes 3-12 months, and worsening balance, weakness, or numbness should be reviewed sooner rather than waiting for a routine retest.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). aPTT Normal Range: D-Dimer, Protein C Blood Clotting Guide. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Serum Proteins Guide: Globulins, Albumin & A/G Ratio Blood Test. Kantesti AI Medical Research.
📖 External Medical References
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.